An experiment was conducted to establish the effect of feeding either refined coconut oil (CO) or copra meal containing CO to beef heifers on DMI, animal performance, enteric CH4 emissions, diet digestibility, and the fatty acid profile of the resulting meat. Forty-one Charolais and Limousin crossbred beef heifers (474 +/- 29 kg; 661 +/- 89 d of age) were blocked by BW before being assigned in a randomized complete block design to 1 of 3 experimental treatments (n = 12) or to a pretrial slaughter group (n = 5) used to determine the initial carcass weight. The experimental period lasted for 93 d. Enteric CH4 output was recorded for 2 periods of 5 consecutive days from d 14 to 18 and from d 70 to 74. The 3 dietary treatments were 1) control, a barley/soybean meal-based concentrate with 0 g of CO/ d; 2) RCO, a barley/soybean meal-based concentrate with 250 g of CO/d from refined coconut oil; and 3) CM, a copra meal-based concentrate with 250 g of CO/d from copra meal. Each diet had a 50:50 forage:concentrate using grass silage as the forage source. There was no effect of diet on DMI (P = 0.734) or GE intake (P = 0.486). The addition of RCO increased ADG (P < 0.05) compared with the control treatment. The CM treatment decreased (P < 0.05) average daily carcass gain compared with the RCO treatment only. There was a decrease (P < 0.05) in the digestibility of the DM, OM, CP, and GE fractions of the diet only with the CM treatment. Both the RCO and CM concentrates decreased (P < 0.001) daily enteric CH4 output when expressed in terms of liters per day, liters per kilogram of DMI, percentage of GE intake, liters per kilogram of ADG, and liters per kilogram of average daily carcass gain. The RCO treatment produced the greatest numerical response for all measures. Ruminal protozoa numbers on the RCO treatment were lower (P < 0.05) than on the control treatment. The concentrations of the fatty acid methyl esters, lauric (P < 0.001) and myristic (P < 0.002) acids, were increased in muscle when either of the CCO treatments was compared with the controls, but the differences were of a magnitude unlikely to influence human health status. Although the CM concentrate decreased CH4 comparable with the RCO concentrate, decreased performance resulted in an extended finishing time with implications for lifetime CH4 emissions.
An experiment was conducted to establish the effects of feeding refined soy oil (RSO) or whole soybeans (WSB) containing soy oil on DMI, animal performance, and enteric methane (CH4) emissions in young bulls. Thirty-six Charolais and Limousin cross-bred, young beef bulls (338 +/- 27 kg of BW, 218 +/- 17 d of age at the beginning of the experiment) were blocked by BW, age, and breed before being assigned in a randomized complete block design to 1 of 3 experimental treatments (n = 12). The experimental period lasted for 103 d, with enteric CH4 output recorded for 2 periods of 5 consecutive days on d 37 to 41 and d 79 to 83. The 3 dietary treatments consisted of a barley/soybean meal-based concentrate with 0 g/d of RSO; oil from WSB as 6% of DMI (WSB treatment); and oil from RSO as 6% of DMI (RSO treatment). Each diet had a 10:90 forage:concentrate ratio, using barley straw as the forage source. Diet affected DMI (P < or = 0.001) and GE intake (P < 0.05 during the CH4 measurement periods), with the WSB treatment producing the lowest values. The addition of WSB decreased ADG (P < 0.05) compared with the RSO treatment. The WSB treatment also decreased (P < 0.05) average daily carcass gain (ADCG). Both the RSO and WSB concentrates decreased (P < 0.05 to P < 0.001) daily enteric CH4 output when expressed in terms of liters per day, liters per kilogram of DMI, percentage of GE intake, liters per kilogram of ADG, and liters per kilogram of ADCG. Diet had no effect (P = 0.557) on ruminal protozoal numbers. The reductions in enteric CH4 were achieved at relatively high oil inclusion levels. Such oil levels have previously been reported to decrease DMI of high-forage diets, although no effect on DMI was noted with the low-forage diets fed in this experiment. This impact on DMI of high-forage diets may limit the range of diets for which this CH4 reduction strategy may be applicable. The inclusion level of WSB in the current experiment (27%) was beyond the palatability threshold of the bulls used and resulted in a marked decline in intake and performance. Therefore, WSB may have a role to play in ruminant diets, but only at a reduced inclusion rate.
This experiment sought to establish the response to increasing levels of coconut oil (CO) supplementation with a fixed 0·50:0·50 forage:concentrate diet on intake, digestibility and methane (CH4) emissions. Sixteen continental cross beef heifers (mean starting weight 481±36 kg) were assigned randomly to one of four levels of CO; 0 g/day, 125 g/day, 250 g/day or 375 g/day in an incomplete (three periods) multiple (no. =4) Latin-square design experiment (no. =12 per treatment). A linear reduction in CH4 output occurred as the level of CO in the diet increased ( P<0·001) with the greatest reduction at the 375 g/day level (394, 341, 314 and 240 l/day for animals fed 0, 125, 250 and 375 g/day CO, respectively). As the level of CO increased dry-matter (DM) intake (DMI) decreased, however these differences were only statistically significant at the 375 g/day level ( P <0·001). The proportional reduction in CH4 output was greater than the proportional reduction in DMI and hence CH4 l/kg DMI decreased from 39·8 l/kg when no CO was given to 29·7 l/kg when 375 g/day CO was given. The addition of CO to the diet resulted in a significant decline in dry-matter digestibility (DMD) at the 375 g/day level (P<0·05). These data demonstrate that the inclusion of CO at levels from 0·013 to 0·045 of the dietary DM within a 0·50:0·50 silage and concentrate ration reduces CH4 production with no adverse effect on DMI or DMD up to the 250 g/day level (0·027 of dietary DM).
To measure parent knowledge levels and opinions related to the human papillomavirus (HPV) and the two vaccines used to prevent it. To measure parent behavior in terms of whether or not to have their children vaccinated. Between June 19, 2012, and August 24, 2012, questionnaires were distributed to parents while waiting for their child to see their pediatrician at a local group practice. The survey was reviewed for face validity by College of Pharmacy social science and clinical faculty members, and an earlier version of it had been used successfully in a published study of biomedical students' knowledge of and attitudes toward the HPV vaccine. 129 usable surveys were obtained. 48.1% of subjects said they learned about the HPV vaccines from the media, while 47.3% identified health care practitioner(s) as a source of knowledge. The mean score on a 20-item knowledge test regarding the infection and vaccines was 36% (range 0-80%). Opinions on the subject varied widely. For example, 22.4% of subjects agreed that schools should require that students be vaccinated before enrolling, while 3.2% agreed that vaccination causes patients to become sexually active. Subjects reported vaccination status for 253 children (mean age 13) as follows: 33% vaccinated; 28% not vaccinated but will be; 11% will never be vaccinated; and 28% not decided. These results are somewhat encouraging, because many parents are hearing about the vaccines from their providers. Although not an equally valid source, the media are also raising awareness. Based on the knowledge and opinion results of this study, there is a need for pharmacists and other providers to educate their patients about the vaccines and the virus and to converse with them regarding the moral and psychological implications of vaccination. Still, it is encouraging that these subjects had or plan to have over half (61%) of their children vaccinated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.